Intravenous Epoprostenol versus High Dose Inhaled Iloprost for Long-term Treatment of Pulmonary Hypertension

Frank Reichenberger (1) , Ann Mainwood (1) , Nicholas W. Morrell (1) , Jayan Parameshwar (1) , Joanna Pepke-Zaba (1)

1 Papworth Hospital

Intravenous prostacyclin (iv PGI) and inhaled Iloprost (inh ilo) are established therapies in pulmonary arterial hypertension (PAH), however comparative data are lacking.

Mots clés: pulmonary hypertension; epoprostenol; high dose Inhaled iloprost; long-term treatment

Domaines: Pneumologie et système respiratoire

Frank Reichenberger, Ann Mainwood, Nicholas W. Morrell, Jayan Parameshwar, Joanna Pepke-Zaba. Intravenous Epoprostenol versus High Dose Inhaled Iloprost for Long-term Treatment of Pulmonary Hypertension. Pulmonary Pharmacology & Therapeutics, 2011, 24 (1), pp.169. ⟨10.1016/j.pupt.2010.06.004⟩. ⟨hal-00721579⟩